Skip to content

Author

Li-Ping Dou

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

THAP7-AS1 sponges miR-4286 to upregulate PFKFB2, accelerating aerobic glycolysis and aggravating liver cancer progression

Background Liver cancer ranks among the most prevalent and deadliest malignancies worldwide. As one of the largest metabolic organs, the liver undergoes profound metabolic reprogramming, encompassing oxidative phosphorylation and aerobic glycolysis (the Warburg effect)-a hallmark of liver cancer progression that drives...

Qiong-Qing Huang, Jingjing Xia, Zhengui Liang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.